Company Profile

Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch's development stage product candidates include the AC5® Topical Gel and the AC5® Surgical Hemostatic Device.

Stock Information

ARTH Symbol
OTCQB Market
Market Cap
Price
Change
Volume
Go to Detailed Stock Info ›

Upcoming Events

Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2020 Annual Meeting

Huntington Convention Center in Cleveland, OH

View IR Calendar ›